David Raichlen's research lab focuses on understanding how sedentary behavior affects brain health and the risk of developing Alzheimer's disease. By examining the relationship between how much time people spend sitting and their cognitive functions, the lab aims to uncover important factors that could help in preventing Alzheimer's disease. The lab uses large datasets like the UK Biobank to assess the impact of lifestyle changes on brain health in older adults.

Dr. David D. McKemy's lab at the University of Southern California focuses on how our body senses cold temperatures and the resulting pain that may occur. The research explores the mechanisms of cold sensitivity and how injury can heighten this sensation, as well as how these processes can be utilized for therapeutic purposes. Ultimately, the lab aims to understand the complex biology behind cold-induced pain to develop better treatments for conditions like chronic pain and allodynia.

Dr. Jeanne Shen's lab focuses on improving treatment outcomes for colorectal cancer using advanced machine learning techniques. They are creating sophisticated models that analyze a combination of medical imaging, pathology slides, and clinical records to better predict patient risk and treatment effectiveness. The research aims to make these tools publicly available to help other researchers and clinicians enhance cancer care more broadly.

Dr. Deborah L. Stenkamp's lab at the University of Idaho focuses on understanding how specific genes control the development of the retina, particularly the cones responsible for color vision. The team investigates the molecular mechanisms and endocrine signals that govern the expression of these genes, with implications for treating conditions like color blindness and age-related macular degeneration. By studying zebrafish and utilizing advanced genetic techniques, the lab aims to uncover how genes can be manipulated to support vision recovery.

Dr. Sougata Roy's research lab at the University of Maryland focuses on how cells communicate with one another during animal development. By studying a model organism called Drosophila (fruit fly), the lab investigates the role of specialized structures called cytonemes, which are used by cells to physically send and receive important signaling molecules. Understanding these communication processes could provide insights into developmental diseases and contribute to advances in tissue engineering.

Dr. Yosuke Kumamoto's lab at Rutgers focuses on understanding a specific type of immune cell called conventional dendritic cells (cDC2s) and their role in allergic responses and autoimmune diseases. The team is investigating how different subsets of these cells are formed in various organs and how they contribute to immune responses to allergens and parasites. Their work aims to uncover the mechanisms behind the differentiation of these immune cells, which could lead to new treatments for allergies and related health issues.

Dr. Jian-Kang Chen's research lab focuses on understanding how diabetes affects kidney function, particularly how it increases the risk of acute kidney injury (AKI). The lab investigates the cellular and molecular changes that lead to kidney hypertrophy and susceptibility to damage in diabetic patients. Their work aims to find new therapeutic targets for preventing kidney damage in these patients, ultimately improving health outcomes for those with diabetes-related kidney issues.

Dr. Coen Ottenheijm's lab at the University of Arizona focuses on understanding how the diaphragm muscle functions in health and in conditions like mechanical ventilation. By studying the interactions between key proteins in the diaphragm, particularly titin and myosin, the lab aims to uncover the reasons behind diaphragm weakness, especially in ICU patients. This research has implications for improving the management of patients requiring prolonged ventilation.

Dr. Xianghong Jasmine Zhou's lab focuses on developing innovative methods for early cancer detection, particularly through the analysis of cell-free DNA (cfDNA) and methylation patterns. By integrating advanced technologies and computational methods, the lab aims to accurately identify and localize cancers such as lung, liver, and gastrointestinal cancers in a non-invasive manner. Their research has the potential to significantly improve patient outcomes by catching cancers earlier than ever before.

Dr. Richard Gregory's lab focuses on understanding the role of RNA modifications in cancer, particularly how these changes can influence gene expression and cancer progression. By studying tRNA and mRNA modifications, the lab aims to uncover novel therapeutic targets for cancer treatment. Their research involves advanced techniques such as RNA mass spectrometry and high-throughput screening to identify potential drugs to combat cancer.

Dr. Christina Farr Zuend's lab at Case Western Reserve University focuses on understanding infertility in couples, particularly in the context of in vitro fertilization (IVF). The lab investigates the role of the microbiome and immune factors in both female and male reproductive systems to identify potential causes of infertility and improve IVF outcomes. By analyzing samples and interactions between partners, the research aims to discover new therapeutic strategies and predictive models for increasing the chances of successful pregnancies.

Dr. Shankar Thangamani's lab at Purdue University studies Candida auris, a drug-resistant fungus that colonizes the skin and can lead to severe infections in hospitalized patients. The lab focuses on understanding how the skin microbiota influences the growth of this fungus, aiming to uncover mechanisms that could inform new treatment strategies. By examining both the properties of the bacteria on the skin and the host's immune response, the research seeks to provide insights to combat these increasingly common infections.

Dr. Kirill Kiselyov's lab at the University of Pittsburgh focuses on understanding how neuronal cells die in Alzheimer's disease, particularly the role of a protein called GDAP1 in protecting against oxidative damage. The lab investigates the relationship between GDAP1 levels and a harmful compound known as 4-hydroxynonenal (4HNE), which accumulates in the brains of Alzheimer's patients. By studying cellular mechanisms in neuronal models, the lab aims to uncover potential therapeutic strategies for Alzheimer's disease.

Dr. Seong Su Kang's lab at Emory University focuses on understanding how gender differences and specific genes contribute to the development and progression of Alzheimer's disease (AD), particularly in women. The team investigates the roles of the APOE4 gene, a known risk factor for AD, and the hormone follicle-stimulating hormone (FSH) in influencing AD pathology, especially regarding cognitive decline in postmenopausal women. By exploring these connections, the lab aims to uncover new treatment strategies for Alzheimer's disease.

Dr. Daniel Matute's lab focuses on understanding how different species exchange genes and how this impacts evolution. They study hybrid organisms, particularly in the context of the fruit fly Drosophila, to figure out what drives gene exchange and how it influences the creation of new species. By combining fieldwork, genetic analysis, and experimental techniques, the lab aims to unravel the complexities of evolution and its relevance to genetic diversity and human health.

Dr. Wan-Ping Lee's lab at the University of Pennsylvania focuses on understanding Alzheimer's Disease (AD), a major public health concern. The research emphasizes the role of genetic factors, particularly copy number variations (CNVs), in the disease's etiology and progression. By analyzing whole genome sequencing data from a large and diverse population, the lab aims to identify new genetic risk factors and improve strategies for the treatment and prevention of AD.

Dr. Balveen Kaur's lab at Augusta University focuses on developing innovative therapies to treat glioblastoma (GBM), a deadly brain cancer. The lab's primary research investigates the use of oncolytic herpes simplex virus (oHSV) in combination with strategies to block NOTCH signaling, which can enhance the virus's effectiveness against tumors while ensuring safety for brain function. By understanding how these pathways interact, the lab aims to improve treatment options for patients suffering from this challenging disease.

Dr. Slobodan Paessler's lab focuses on understanding and combating arenavirus infections, which cause serious diseases like hemorrhagic fevers. The team is investigating how these viruses rely on certain sugars, namely D-glucose and D-mannose, to survive and replicate. By exploring innovative antiviral strategies, including the use of sugar mimetics, the lab aims to develop new treatment options that could protect against outbreaks and save lives.

Dr. Wenxia Song's lab at the University of Maryland focuses on understanding how the bacteria Neisseria gonorrhoeae infects the female reproductive tract, often without causing symptoms. By studying the immune response and the bacteria's mechanisms of evading detection, the lab aims to improve our knowledge of gonorrhea and develop strategies for prevention and treatment, particularly in the context of rising antibiotic resistance.

Dr. Jean M. Wilson's lab at the University of Arizona focuses on understanding how cytomegalovirus (CMV) infection affects the cells of the colon. The team investigates how CMV alters the barrier function of the colonic epithelium, which is critical for maintaining gut health and preventing diseases like colitis. By studying the interactions between the virus and the colon cells, they aim to uncover new ways to treat and prevent CMV-related complications, especially in immunocompromised patients.